Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1

J. A. Copland, L. A. Marlow, S. Kurakata, K. Fujiwara, A. K.C. Wong, P. A. Kreinest, S. F. Williams, B. R. Haugen, J. P. Klopper, R. C. Smallridge

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1'. Together they form a unique fingerprint.

Medicine & Life Sciences